Chiron Ventures

Chiron Ventures is a Beijing-based investment firm established in 2008 that specializes in the healthcare sector. The firm focuses on innovation and investment in medical health, leveraging its extensive experience and resources in medical technology development and entrepreneurship. Chiron Ventures provides significant support and professional services to its investment projects, aiming to advance medical innovation and market development. Through its targeted approach, the firm seeks to contribute to the growth of the healthcare industry by backing promising ventures that enhance medical solutions and technologies.

Wang Zhiyong

Director

9 past transactions

Ren Labs

Seed Round in 2022
Ren Labs is a multichain technology promoting the research and development of initiatives to expand the Ren ecosystem and the broader blockchain space.

Pulnovo Medical

Venture Round in 2021
Pulnovo Medical specializes in the development and production of innovative medical devices aimed at treating pulmonary hypertension. The company focuses on radiofrequency ablation technology, offering advanced solutions such as pulse radiofrequency ablation catheters and instruments. These pioneering products are designed to enhance the resilience and quality of life for patients suffering from pulmonary hypertension and heart failure. Pulnovo Medical holds global invention patents for its high-frequency ablation equipment and intravascular catheters, reflecting its commitment to advancing treatment methodologies in this critical area of healthcare.

Green Growth Brands

Post in 2019
Green Growth Brands is a lifestyle-oriented, consumer products company that celebrates health, wellness, and happiness. It brings together a collection of retailers, scientists, botanists, developers, artists, and business leaders. The company was founded in 2018 and is headquartered in Ohio.

Chinagene Tech

Corporate Round in 2019
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Wanxu Software

Series A in 2018
Wanxu Software is a Healthcare company.

LungCare

Series A in 2015
Developer of lung cancer diagnostic technology. The company's products include a 3d CT scanner with electromagnetic positioning and a variety of brochoscopes, enabling healthcare professionals to more accurately and efficiently detect lung cancer in patients.

Pulnovo Medical

Seed Round in 2013
Pulnovo Medical specializes in the development and production of innovative medical devices aimed at treating pulmonary hypertension. The company focuses on radiofrequency ablation technology, offering advanced solutions such as pulse radiofrequency ablation catheters and instruments. These pioneering products are designed to enhance the resilience and quality of life for patients suffering from pulmonary hypertension and heart failure. Pulnovo Medical holds global invention patents for its high-frequency ablation equipment and intravascular catheters, reflecting its commitment to advancing treatment methodologies in this critical area of healthcare.

Sino-US Telemed

Angel Round in 2011
Provider of advanced clinical imaging services. The comapny provides medical imaging services including 3D reconstruction, surgery planning, diagnosis, disease screening, and imaging physician training, providing high quality precision medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.